Prolonged vastus lateralis denervation after botulinum toxin type A injection

Movement Disorders

Volumn 25, Issue 3, 2010, Pages 397-401

  Dunne, John W ^a,b   Singer, Barbara J ^b   Silbert, Peter L ^a,b   Singer, Kevin P ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Botulinum A toxin; Electromyography; Muscle denervation; Neuromuscular blockade

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; KNEE DISEASE; KNEE PAIN; MALE; MOTONEURON; MOTOR UNIT POTENTIAL; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE DENERVATION; NEUROPHYSIOLOGICAL RECRUITMENT; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VASTUS LATERALIS MUSCLE; WALKING DIFFICULTY;

ACTION POTENTIALS; BOTULINUM TOXIN TYPE A; ELECTROMYOGRAPHY; HUMANS; INJECTIONS, INTRAMUSCULAR; KNEE INJURIES; LINEAR MODELS; MUSCLE DENERVATION; NEUROMUSCULAR AGENTS; PAIN; QUADRICEPS MUSCLE; TIME FACTORS;

EID: 77649170744     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22852     Document Type: Article

References (14)

1. Dressler D, Hallett M. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc. Eur J Neurol 2006;13(Suppl 1): 11-5.
2. Comella JX, Molgo J, Faille L. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions. Neurosci Lett 1993;153:61-64
3. de Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999;96:3200-3205
4. Juzans P, Comella JX, Molgo J, Faille L, Angaut-Petit D. Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 1996;6:177-185.
5. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 1995;58:232-235.
6. Chiu MJ, Chang YC, Hsiao TY. Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review. Dysphagia 2004;19:52-57.
7. Benecke R, Dressler D. Botulinum toxin treatment of axial and cervical dystonia. Disabil Rehabil 2007;29:1769-1777
8. Schroeder AS, Ertl-Wagner B, Britsch S, Schröder JM, Nikolin S, Weis J, Müller-Felber W, Koerte I, Stehr M, Berweck S, Borggraefe I, Heinen F. Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord. 2009;24:1494-1503.
9. Malone T, Davies G, Walsh WM. Muscular control of the patella. Clin Sports Med 2002;21:349-362.
10. Singer BJ, Silbert PL, Dunne JW, Song S, Singer KP. An open label pilot investigation of the efficacy of Botulinum toxin type A (Dysport) injection in the rehabilitation of chronic anterior knee pain. Disabil Rehabil 2006;28:707-713
11. Bischoff C, Stalberg E, Falck B, Eeg-Olofsson KE. Reference values of motor unit action potentials obtained with multi-MUAP analysis. Muscle Nerve 1994;17:842-851.
12. Stalberg E, Bischoff C, Falck B. Outliers, a way to detect abnormality in quantitative EMG. Muscle Nerve 1994;17:392-399.
13. Kimura J. Nerve conduction and needle electromyography. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, Vol. 1. Elsevier Saunders, Philadelphia 2005. p 937-969.
14. Dresseler D, Rothwell JC. Electromyographic quantification of the paralyzing effect of botulinum toxin. Eur Neurol 2000:43:13-16.